Skip to main content

Livzon Pharmaceutical Group

Livzon Pharmaceutical Group Inc is a Chinese multinational pharmaceutical manufacturing enterprise specializing in the research, development, production, and global wholesale distribution of active pharmaceutical ingredients (APIs), biological formulations, diagnostic reagents, and traditional Chinese medicines, prominently featuring specialized digestive tract medications, anti-infective drugs, reproductive health therapies, and oncological formulations distributed across China and international medical markets. Operating as a core pharmaceutical subsidiary of Joincare Pharmaceutical Group, the company maintains advanced USFDA-compliant chemical synthesis and biological manufacturing complexes in China. Its core business operations encompass pharmaceutical manufacturing, API synthesis, biological drug development, and international wholesale distribution. Revenue is derived directly from the commercial wholesale sale of finished pharmaceutical formulations and bulk APIs to healthcare distributors. Livzon Pharmaceutical Group holds a leading market position in specialty pharmaceutical manufacturing and digestive therapeutics in China. The company is headquartered in Zhuhai, Guangdong Province, China, and its shares trade on the Shenzhen Stock Exchange and the Stock Exchange of Hong Kong.

3 of the funds FundTelligence covers report a position in Livzon Pharmaceutical Group.

Legal name
Livzon Pharmaceutical Group Inc
Sector
Health Care
Country
China
Funds holding it
3

Funds holding Livzon Pharmaceutical Group

Loading...